S0033291721005201jra 3142..3149

Abstract Background Copy number variants (CNVs) have been associated with the risk of schizophrenia, autism and intellectual disability. However, little is known about their spectrum of psychopathology in adulthood. Methods We investigated the psychiatric phenotypes of adult CNV carriers and compared probands, who were ascertained through clinical genetics services, with carriers who were not. One hundred twenty-four adult participants (age 18–76), each bearing one of 15 rare CNVs, were recruited through a variety of sources including clinical genetics services, charities for carriers of genetic variants, and online advertising. A battery of psychiatric assessments was used to determine psychopathology. Results The frequencies of psychopathology were consistently higher for the CNV group compared to general population rates. We found particularly high rates of neurodevelopmental disorders (NDDs) (48%), mood disorders (42%), anxiety disorders (47%) and personality disorders (73%) as well as high rates of psychiatric multimorbidity (median number of diagnoses: 2 in non-probands, 3 in probands). NDDs [odds ratio (OR) = 4.67, 95% confidence interval (CI) 1.32–16.51; p = 0.017) and psychotic disorders (OR = 6.8, 95% CI 1.3–36.3; p = 0.025) occurred significantly more frequently in probands (N = 45; NDD: 39[87%]; psychosis: 8[18%]) than non-probands (N = 79; NDD: 20 [25%]; psychosis: 3[4%]). Participants also had somatic diagnoses pertaining to all organ systems, particularly conotruncal cardiac malformations (in individuals with 22q11.2 deletion syndrome specifically), musculoskeletal, immunological, and endocrine diseases. Conclusions Adult CNV carriers had a markedly increased rate of anxiety and personality disorders not previously reported and high rates of psychiatric multimorbidity. Our findings support in-depth psychiatric and medical assessments of carriers of CNVs and the establishment of multidisciplinary clinical services.

[1]  W. Chung,et al.  The psychiatric phenotypes of 1q21 distal deletion and duplication , 2021, Translational Psychiatry.

[2]  M. Owen,et al.  Clinical evaluation of patients with a neuropsychiatric risk copy number variant , 2021, Current opinion in genetics & development.

[3]  Jijun Wang,et al.  Screening of the college students at clinical high risk for psychosis in China: a multicenter epidemiological study , 2020, BMC Psychiatry.

[4]  D. Ledbetter,et al.  Identification of Neuropsychiatric Copy Number Variants in a Health Care System Population , 2020, JAMA psychiatry.

[5]  W. Chung,et al.  A Genetics-First Approach to Dissecting the Heterogeneity of Autism: Phenotypic Comparison of Autism Risk Copy Number Variants. , 2020, The American journal of psychiatry.

[6]  David E. J. Linden,et al.  Electrophysiological network alterations in adults with copy number variants associated with high neurodevelopmental risk , 2019, bioRxiv.

[7]  A. Thompson,et al.  The prevalence of personality disorders in the community: a global systematic review and meta-analysis , 2019, The British Journal of Psychiatry.

[8]  D. Skuse,et al.  Genotype-phenotype associations in children with copy number variants associated with high neuropsychiatric risk in the UK (IMAGINE-ID): a case-control cohort study. , 2019, The lancet. Psychiatry.

[9]  P. Déchelotte,et al.  Prevalence of eating disorders over the 2000-2018 period: a systematic literature review. , 2019, The American journal of clinical nutrition.

[10]  G. Kirov,et al.  Association of Rare Copy Number Variants With Risk of Depression , 2019, JAMA psychiatry.

[11]  M. Owen,et al.  Epilepsy and seizures in young people with 22q11.2 deletion syndrome: Prevalence and links with other neurodevelopmental disorders , 2019, Epilepsia.

[12]  Derek K. Jones,et al.  Genetic risk for schizophrenia and developmental delay is associated with shape and microstructure of midline white-matter structures , 2018, bioRxiv.

[13]  Haniye Sadat Sajadi,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, The Lancet.

[14]  S. Rabung,et al.  Prevalence of personality disorders in the general adult population in Western countries: systematic review and meta-analysis. , 2018, The British journal of psychiatry : the journal of mental science.

[15]  Derek K. Jones,et al.  Genetic risk for schizophrenia and developmental delay is associated with shape and microstructure of midline white matter structures , 2018, bioRxiv.

[16]  J. Vermeesch,et al.  Neurodevelopmental risk copy number variants in adults with intellectual disabilities and comorbid psychiatric disorders , 2018, British Journal of Psychiatry.

[17]  B. Moreno-Küstner,et al.  Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses , 2018, PloS one.

[18]  C. Gyamfi‐Bannerman,et al.  Epidemiology of preterm birth. , 2017, Seminars in perinatology.

[19]  Sunny X. Tang,et al.  Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study , 2017, Schizophrenia bulletin.

[20]  Michael J. Owen,et al.  Cognitive Performance Among Carriers of Pathogenic Copy Number Variants: Analysis of 152,000 UK Biobank Subjects , 2017, Biological Psychiatry.

[21]  Peter B. Jones,et al.  Phenotypic Manifestation of Genetic Risk for Schizophrenia During Adolescence in the General Population. , 2016, JAMA psychiatry.

[22]  Peter J. Scambler,et al.  22q11.2 deletion syndrome. , 2015, Nature reviews. Disease primers.

[23]  G. Salum,et al.  Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. , 2015, Journal of child psychology and psychiatry, and allied disciplines.

[24]  H. Chambers,et al.  Effects of caregiving on the families of children and adults with disabilities. , 2015, Physical medicine and rehabilitation clinics of North America.

[25]  Brian Chung,et al.  Practical guidelines for managing adults with 22q11.2 deletion syndrome , 2015, Genetics in Medicine.

[26]  Sunny X. Tang,et al.  Subthreshold psychotic symptoms in 22q11.2 deletion syndrome. , 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

[27]  V. Patel,et al.  The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. , 2014, International journal of epidemiology.

[28]  G. Kirov,et al.  The Penetrance of Copy Number Variations for Schizophrenia and Developmental Delay , 2014, Biological Psychiatry.

[29]  John O. Willis,et al.  Wechsler Abbreviated Scale of Intelligence , 2014 .

[30]  G. Kirov,et al.  Analysis of copy number variations at 15 schizophrenia-associated loci , 2014, The British journal of psychiatry : the journal of mental science.

[31]  Bradley P. Coe,et al.  A genetic model for neurodevelopmental disease , 2012, Current Opinion in Neurobiology.

[32]  Stephen J. Blumberg,et al.  Trends in the Prevalence of Developmental Disabilities in US Children, 1997–2008 , 2011, Pediatrics.

[33]  T. McGlashan,et al.  The Psychosis-Risk Syndrome: Handbook for Diagnosis and Follow-Up , 2010 .

[34]  J. Sebat,et al.  Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. , 2009, Trends in genetics : TIG.

[35]  S. Leekam,et al.  The Diagnostic Interview for Social and Communication Disorders: background, inter-rater reliability and clinical use. , 2002, Journal of child psychology and psychiatry, and allied disciplines.

[36]  C. Hatton,et al.  Reliability and validity of the PAS-ADD Checklist for detecting psychiatric disorders in adults with intellectual disability. , 1998, Journal of intellectual disability research : JIDR.

[37]  R. Barrett,et al.  Epilepsy and Seizures. , 2006 .

[38]  Godfrey D Pearlson,et al.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. , 2003, Schizophrenia bulletin.

[39]  N. Andreasen Methods for assessing positive and negative symptoms. , 1990, Modern problems of pharmacopsychiatry.